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Background: The mammary gland is key to all mammal species; in particular in multiparous species like pigs the
number and the shape of functional mammary gland complexes are major determinants of fitness. Accordingly, we
aimed to catalog the genes relevant to mammogenesis in pigs. Moreover, we aimed to address the hypothesis that
the extent and timing of proliferation, differentiation, and maturation proccesses during prenatal development
contribute to postnatal numerical, morphological and functional properties of the mammary gland. Thus we
focused on differentially expressed genes and networks relevant to mammary complex development in two breeds
that are subject to different selection pressure on number, shape and function of teats and show largely different
prevalence of non-functional inverted teats. The expression patterns of fetal mammary complexes obtained at 63
and 91 days post conception (dpc) from German Landrace (GL) and Pietrain (PI) were analyzed by Affymetrix
GeneChip Porcine Genome Arrays.
Results: The expression of 11,731 probe sets was analysed between the two stages within and among breeds. The
analysis showed the largest distinction of samples of the breed GL at 63 dpc from all other samples. According to
Ingenuity Pathways Analysis transcripts with abundance at the four comparisons made (GL63-GL91, PI63-PI93,
GL63-PI63 and GL91-PI91) were predominantly assigned to biofunctions relevant to `cell maintenance, proliferation,
differentiation and replacement´, `organismal, organ and tissue development´ and `genetic information and nucleic
acid processing´. Moreover, these transcripts almost exclusively belong to canonical pathways related to signaling
rather than metabolic pathways. The accumulation of transcripts that are up-regulated in GL compared to PI
indicate a higher proliferating activity in GL, whereas processes related to differentiation, maturation and
maintenance of cells are more prominent in PI. Differential expression was validated by quantitative RT-PCR of five
genes (GAB1, MAPK9, PIK3C2B, PIK3C3 and PRKCH) that are involved in several relevant signaling pathways.
Conclusions: The results indicate that mammary complex development in PI precedes GL. The differential
expression between the two breeds at fetal stages likely reflects the prenatal initiation of postnatal phenotypes
concerning the number and shape as well as functionality of teats.* Correspondence: wimmers@fbn-dummerstorf.de
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The development of the mammary gland is initiated during
fetal stage. In the pig, the first visible structure at embry-
onic day 23 to 28 (E23 to E28) are elevated epidermal
ridges or milk lines which are extending between forelimb
to hindlimb on each side of trunk. The milk lines are a
thickening of the ectoderm or the epidermis which are
then fragment into individual buds. The formation of
mammary placodes appears along each side of the body. In
between E28 and E40, the placodes develop into bulb-
shaped buds of epithelial cells by invagination into the
underlying mesenchyme. Subsequently the size of the
buds is slowly increasing and at E80 the mesenchymal cells
surrounding the epithelial buds start to condense to be-
come the mammary mesenchyme. Only late in prenatal
development the epithelial buds elongate to the mammary
mesenchyme to form a sprout, which creates a small duct.
The sprout penetrates through fat pads. It starts to the
ductal elongation and side branching about 10–15 times to
form a rudimentary ductal tree. The mammary glands
remain at this rudimentary stage, while the epithelial duct
slowly grows until it reaches puberty [1-5].
Essentially, the development of mammary gland depends
on growth hormones and growth factors. Moreover, the
mammary gland development at fetal stages is apparently
autonomous. The initiation of the mammary gland devel-
opment and the early stage of morphogenesis are con-
trolled by reciprocal interaction between epithelial and
surrounding mesenchymal cells. The differentiation of
mammary epithelia is also induced by the mammary mes-
enchyme [6-8]. During the differentiation at fetal stages
the fate of cells towards their specialization as member
of a population of cells typical for a tissue or organ is
programmed. Accordingly, fetal development has implica-
tions on postnatal phenotypes. The mammary gland is key
to all mammal species; in multiparous pigs the number
and the shape of functional mammary gland complexes
are major determinants of the mothering ability of sows.
In order to catalog genes relevant to mammogenesis in
pigs, we analyzed the transcriptome of the mammary
buds at the phase of formation and growth, i.e. at 63 day post
conception (dpc) and 91 dpc, when epithelial and mesenchy-
mal cell undergo proliferation and differentiation processes.
In order to address the hypothesis that balancing of
proliferation and differentiation of epithelial and mesen-
chymal cells during prenatal development contributes to
the postnatal shape and functionality of the mammary
gland we compared fetal specimens obtained from two
divergent breeds, German Landrace and Pietrain. Whereas
in dam lines like German Landrace young sows are
strongly selected for numerical, morphological and func-
tional properties of the mammary gland, in sire lines
like Pietrain these are not obligatory selection criterion.
Accordingly, mammary complexes of both breeds differ interms of number of teats and their distribution along the
body and their symmetry at bold sides as well as the
occurrence of additional non-functional teats including
inverted teats. In fact, the examination of teat complexes
of more than 2000 carcasses at the abattoir revealed mean
teat numbers of around 15 and 13 in German Landrace
and Pietrain, respectively [9, own observations]. The breeds
also differ in the number of non-functional teats; interest-
ingly, we observed different incidences of inverted teats
of 12% in dam lines and 48% in Pietrain [10,11]. Thus
differences of expression profiles of prenatal teat tissues
between the two breeds could be indicative for molecular
routes impertinent for the postnatal morphology and func-
tionality of the mammary complexes.
The inverted teat defect is a polygenetic inherited liabil-
ity trait marked by a decrease the number of functional
teats thus causing animal welfare concerns due to
increased piglet mortality and incidence of mastitis. It
has been suggested that impaired prenatal development
contributes to the emerging of inverted teats [10,12].
Moreover, we have previously demonstrated that genes of
growth factor signaling pathways show differential expres-
sion depending on the teat phenotype and the affection
status of the individual [11,13]. We aimed to elucidate
whether molecular routes found to be affected due to the
development of inverted teats at postnatal stages may
already play a role during prenatal development. However,
at prenatal stages the phenotype of inverted teat is not
yet visible and the development of the teats cannot be
predicted. In general, beside clones of animals that express
a certain trait that is only visible during postnatal life but
that is initiated by prenatal events, fetal samples of breeds
that largely differ in that trait are the best available model.
The study was conducted with commercial genome-wide
microarray (Affymetrix GeneChip Porcine Genome Array)
to identify the differentially expressed genes and networks
relevant to the development of mammary complexes in
the two breeds and contributes to the understanding of
molecular routes relevant to postnatal emergence of differ-
ences in morphological and functional properties.
Results
Gene expression
In order to identify differential gene expression in mam-
mary gland development depending on stage (63 dpc and
91 dpc) and breed (GL and PI) probe sets (subsequently
also referred to as genes or transcripts) with present calls
in at least 50% of the samples were selected for statistical
analysis summing up to 11,731 probe sets. Differential
expression was evaluated between breeds within stages.
Further we listed differentially expressed genes (DE-genes)
between stages within breed. These two lists of DE-genes
were compared. The commonly temporally regulated
genes were considered separate from those genes that
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the later reflect breed differences, whereas commonly
regulated genes between stages in both breeds are not
likely to contribute to the initiation of divergence of the
postnatal phenotype among the breeds. The numbers of
significant differentially expressed genes are summarized
in Figure 1. Fold changes (FC) varied between 1.2 and
50.2. Most pronounced differences were found between
breeds at stage 63 dpc: at p< 0.05 corresponding to
q=0.005-0.03 there were 4787 DE-genes with median FC
of 2.1 and a maximum FC of 50.2. Also between stages
within the breed GL considerable transcriptomic differ-
ences were obvious (number of DE-genes: 1758 at p< 0.05
corresponding to q=0.001-0.14; FCmedian = 1.7; FCmax=
19.2; number of DE-genes temporally regulated but specific
to GL: 1450 at p< 0.05 corresponding to q=0.001-0.14;
FCmedian = 1.8; FCmax=11.4), whereas between stages 63
dpc and 91 dpc in PI (number of DE-genes: 734 at p< 0.05
corresponding to q=0.04-0.8; FCmedian = 1.6; FCmax=25.4;
number of DE-genes temporally regulated but specific to
PI: 426 genes at p< 0.05 corresponding to q=0.04-0.8;
FCmedian = 1.7; FCmax=19.7) and among GL and PI at 91
dpc (number of DE-genes: 463 at p< 0.05 corresponding to
q=0.5; FCmedian = 1.7; FCmax=11.9) the distinctness of the
expression profiles was moderate.Ingenuity pathway analysis
Four lists of DE-genes were imported to the Ingenuity
Pathways Analysis (IPA) in order to assign them to
groups or categories of biofunctions and to canonical
pathways as defined in the Ingenuity Knowledge Base
(Genes) and to test for significant enrichment of DE-Figure 1 The number of significant differentially expressed
genes in same breeds or stages and different breeds or stages.
in bold: numbers of transcripts with difference abundance at the
respective comparisons (GL63-GL91, PI63-PI93, GL63-PI63 and
GL91-PI91) at p< 0.05. in parenthesis: number of transcripts with
higher or lower abundance relative to the breed PI ("=PI higher or
#=PI lower)during development from 63 dpc to 91 dpc
("= increase, #=decrease).genes within these groups. The DE-genes were predomin-
antly assigned to biofunctions relevant to `cell maintenance,
proliferation, differentiation and replacement´, `organismal,
organ and tissue development´ and `genetic information
and nucleic acid processing´. Referring to the most signifi-
cant functions named by IPA within the IPA-categories
listed in Figures 2, 3, 4, 5 elucidates the developmental
status of the mammary gland tissues within the four
groups compared here. Those genes that are higher
expressed in PI than in GL at 63 dpc were assigned to
genetic information processing, in particular transcription
and transactivation (IPA-category: `gene expression´), cel-
lular processes including formation of filaments and inter-
cellular junction (IPA-category: `cellular assembly and
organization´), survival of cells (IPA-category: `cell death),
and cytostasis (IPA-category: `cellular function and main-
tenance´)(Figure 2A). At 63 dpc in DL many genes anno-
tated to biofunctions related to genetic information and
nucleic acid processing are higher expressed than in PI;
this covers functions of transcription (IPA-category: `gene
expression´), RNA processing and splicing (IPA-category:
`RNA post-transcriptional modification´), apoptosis (IPA-
category: `cell death´) but also cell division (IPA-category:
`cell cycle´) and also includes genes relevant to early onset
of breast cancer (IPA-category: `genetic disorder´)
(Figure 2B). The accumulation of DE-genes that are up-
regulated in DL compared to PI indicate a higher prolifer-
ating activity in DL, whereas processes related to mainten-
ance and differentiation and maturation of cells are more
prominent in PI at 63 dpc.
At 91 dpc biofunctions related to cellular development
are predominantly regulated in both breeds (Figure 3A, B).
In GL genes with function in cell differentiation
including the processes involved in commitment of a cell
to a specific fate and its subsequent development to the
mature state (IPA-category: `cellular development´) as
well as stem cell proliferation (IPA-category: `cellular
growth and proliferation´) are up-regulated compared to
PI (Figure 3B). Cell maturation, i.e. developmental pro-
cesses, independent of morphogenetic (shape) change,
that are required for a cell to attain its fully functional
state (IPA-category: `cellular development´) and growth
(IPA-category: `cellular growth and proliferation´) are
biofunctions covering a significant number of genes
higher expressed in PI than in GL at 91 dpc (Figure 3A).
Thus also at 91 dpc the results suggest that the tissue of
the mammary complex has already reached a higher
degree of maturity in PI than GL. However, none of the
transcripts considered here in this comparison among
breeds at 91 dpc reached a false discovery rate below 0.5.
Corresponding to the differential regulation between
breeds within stages the temporal regulation between 63
dpc and 91 dpc that is limited to PI indicates a high
expression of genes related to differentiation and
Figure 2 Significant biofunctions (top ten according to p-value) representing genes differentially expressed between samples of
mammary complexes of Pietrain and German Landrace at 63 dpc. (A) PI>GL (B) PI<GL. All assignments significant after Benjamini–
Hochberg correction, except `tissue development´, `cell death´, cell-to-cell signaling´, `cellular function and maintenance´, and `molecular
transport´ in (A).
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`cell death´), organization of organelles and cytoskeleton
(IPA-category: `cellular assembly and organisation´) and
remodelling of tissue and quantity of connective tissue
cells (IPA-categories: `connective tissue development
and function´ as well as `tissue morphology´) (Figure 4).
When only taking into account transcripts with different
abundance at p< 0.001 (corresponding to q< 0.27) 44 re-
main that do not provide a meaningful IPA. The temporally
regulated genes that are restricted to the breed GL were
assigned to processes impertinent to dynamic changes of
the cell population within the tissue at 63 dpc with func-
tions like proliferation of cells (IPA-category: `cellular
growth and proliferation´), transcription (IPA-category:
`gene expression´), apoptosis (IPA-category: `cell death´),
and cell migration (IPA-category: `cellular movement´) (Fig-
ure 5). Assignment to biofunctions of commonly regulated
genes between stages in both breeds is shown in the supple-
mentary material (Additional file 1: Figure S1).IPA towards assignment of DE-genes to canonical
pathways pointed to signaling pathways important for
cellular proliferation, differentiation, development and
growth as detailed in Tables 1 and 2. We selected five
genes (GAB1, MAPK9, PIK3C2B, PIK3C3 and PRKCH)
that are involved in several signaling pathways and
therefore were redundantly listed (in bold in Tables 1
and 2) for examination of their expression by qRT-PCR
(Figure 6). In general, the breed and stage dependent
differences of relative transcript abundance as found by
microarray analysis and qRT-PCR were in good agree-
ment (Figure 6). The relative transcript abundance
according to microarrays and qRT-PCR were signifi-
cantly correlated at R² = 0.49 - 0.65, except for MAPK9.
For MAPK9 microarrays indicated highest expression
GL at 63 dpc, whereas qRT-PCR indicated an even
higher expression in GL at 91 dpc; however in both ana-
lyses expression in PI was lower than in GL at any of the
two stages.
Figure 3 Significant biofunctions (top ten according to p-value) representing genes differentially expressed between samples of
mammary complexes of Pietrain and German Landrace at 91 dpc. (A) PI>GL (B) PI<GL. All assignments significant after Benjamini–
Hochberg correction.
Chomwisarutkun et al. BMC Developmental Biology 2012, 12:13 Page 5 of 16
http://www.biomedcentral.com/1471-213X/12/13Discussion
Differential expression at bud formation and growth
among divergent breeds
The mammary gland development begins during fetal
development and proceeds through the adult life. The
fetal mammary gland development in pigs initiates at day
23 (E23) with the formation of the milk lines and
continues with the invagination of epithelial cells to form
buds that subsequently increase in size accompanied by
the condensation of surrounding mesenchymal cells. The
mammary gland development at fetal stages depends on
the signal between epithelium and surrounded mesen-
chyme. Epithelial and mesenchyme are found in every
organ. Either the transitions of epithelial into mesenchyme
or the transitions of mesenchyme into epithelial is the
cause of morphogenesis, differentiation and growth during
the development [14]. A mesenchymal-epithelial inter-
action is a reciprocal process, where mesenchyme induces
the formation of epithelial, while epithelium induces mes-
enchymal differentiation [15,16]. In fetal mammary glanddevelopment, mammary mesenchyme induces the forma-
tion of mammary epithelial buds when they were combined
with the epidermis. The mammary buds induce the expres-
sion of androgen receptors (AR) and tenascin in mesenchy-
mal cells and then the formation of the primary mammary
mesenchyme occurs [15]. The insufficient proliferation of
mesenchyme in embryonic mammary development may
cause the inverted teat [13].We analysed samples 63 dpc
and 91 dpc during growth of buds and their protrusion by
mesenchymal cell development that is important for the
postnatal shape and function of teats. Furthermore,
hypothesising that the prenatal development of the buds
affects the postnatal phenotype of teats we compared
samples of two breeds that are subject to different selection
pressure on number, shape and function of teats. The
analysis of differential expression in the fetal tissues at the
two time points between the two breeds showed the largest
distinction of samples of the breed GL at 63 dpc from all
other samples. Accordingly, the identification of transcripts
with different abundance in specimens of GL at 63 dpc
Figure 4 Significant biofunctions (top ten according to p-value) representing genes differentially expressed in Pietrain at 63 dpc
compared to 91 dpc. (A) 63 dpc< 91 dpc (B) 63 dpc> 91 dpc. All assignments significant after Benjamini–Hochberg correction.
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or compared to that of GL of a later stages (91 dpc) at p
< 0.05 was achieved with considerable low false discovery
rates (q≤ 0.03 and q≤ 0.14, respectively). Together with the
relatively large differences between 63 dpc and 91 dpc in
GL and moderate divergence between early and late PI
samples as well as between GL 91 dpc and PI 91 dpc this
indicates that in GL at 63 dpc a less progressed status
has been reached and catching up on the development
proceeds until 91 dpc. The assignment of DE-genes to
biofunctions and canonical pathways underline the rela-
tively delayed development in GL compared to PI in termsof differentiation, maintenance, and maturation and a thus
prolonged proliferative phase.
DE genes essentially belong to signaling pathways
The development of embryonic mammary gland can be
divided into several steps as described above. Many
known genes were regulated in each stage of mammary
development. These genes were assignment to signaling
pathways whereas expression of genes of metabolic path-
ways was not differentially regulated among the samples.
Previous studies have already addressed a number of genes
of signaling pathways in particular those related to growth
Figure 5 Significant biofunctions (top ten according to p-value) representing genes differentially expressed in German Landrace at 63
dpc compared to 91 dpc. (A) 63 dpc< 91 dpc (B) 63 dpc> 91 dpc. All assignments significant after Benjamini–Hochberg correction.
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(FGFR2) were found differentially expressed in this
study (Table 2). Fibroblast growth factor (FGFs) together
with T-box transcription factor were found in mammary
line in early development and members of the Wnt gene
family were also found in mammary placodes. Members of
the Wnt signaling pathway were differentially expressed
between 63 and 91 dpc. They play a role in the formation
of placodes and mammary epithelial differentiation [17-19].
Lymphocyte enhancer factor-1 (LEF1), an important factor
for the mammary placodes and bud maintenance, is a
transcription factor, which is defined in epithelial cell of
mammary buds and mesenchyme [20]. It was found
regulated due to breed and stage in this study (Tables 1
and 2). The expression of LEF1 is induced by parathyroid
hormone - protein (PTHLP) and its receptor (PTHR1)
[21]. PTHLH (parathyroid hormone like hormone) and
PTHR1 genes were clearly detected in epithelial and
connective teat tissues. Polymorphisms of PTHLH and
PTHR1 as well as LEF1 were associated with the
inverted teat phenotype [22,23]. Studies of mice defi-
cient of FGFs, Wnts, LEF1 and PTHLH show that theseare required for adequate signaling in fetal mammary
development [24-28].
The development of fetal mammary gland largely
depends on interaction between mesenchymal-epithelial.
The basic molecules for signals in mesenchyme-epithelial
interaction are provided by paracrine signaling, which con-
sists of epithelial tyrosine kinase receptors and their mes-
enchymal ligands [29]. Fibroblast growth factor (FGF)
signaling that was addressed in this study, like Hepatocyte
growth factor (HGF) signaling, Growth hormone signaling,
and Epidermal growth factor (EGF) signaling are the main
cellular growth, proliferation and development signaling
pathways. Accordingly, genes (GAB1, MAPK9, PIK3C2B,
PIK3C3 and PRKCH) from signaling pathways were
selected to validate microarray data that all have known
roles in developmental processes.
GRB2-associated binding protein 1 (GAB1) is a member
of the family of docking proteins. GAB1 functions as
a mediator in growth factor signaling and cytokine
receptor, especially in EGF signaling, HGF signaling and
Platelet-derived growth factor (PDGF) signaling which
stimulates the migration of epithelial, mesenchymal and
Table 1 Assignment of temporally regulated DE-genes to canonical pathways in German Landrace and Pietrain, respectively
Ingenuity Canonical
Pathways
63 dpc vs. 91
dpc in GL or PI
p-value1 Ratio2 Molecules
Angiopoietin Signaling GL 0.008 0.143 STAT5A, PAK4, AKT2, IKBKG, TNIP1, GRB14, ANGPT1, PAK6, PTPN11, MRAS, IKBKAP
PI 0.065 0.065 PIK3C2B, PAK4, IKBKG, TNIP1, PIK3R4
Chemokine Signaling GL 0.028 0.133 GNAI3, PLCB4, JUN, MYL2, CXCL12, MRAS, GNAQ, PPP1R12A, MAPK12, CAMK2G
PI 0.393 0.040 CAMK2A, MYL2, CAMK2G
ILK Signaling GL 0.005 0.120 MYH10, AKT2, VEGFB, MYL2, TNFRSF1A, CREB3, MYH11, MAPK12, MYL9, NCK2, RHOQ, JUN, RHOG, IRS1, RHOU, CHD1, MYH9,
LEF1, ACTG2, PTGS2, PPP2R5E, ACTC1, ACTN1
PI 0.002 0.073 PIK3C2B, MYL2, TNFRSF1A, VEGFC, MYH11, PIK3R4, MYL6B, PPP2R5A, ITGB3, PPP2R4, PPP2R2B, MYH3, PTGS2, ACTC1
Integrin Signaling GL 0.011 0.112 CAPN5, FYN, AKT2, PAK4, ARHGAP26, TSPAN7, MYL2, PAK6, ARHGEF7, TNK2, MYLK, NCK2, RHOG, RHOQ, MRAS, RHOU,
PPP1R12A, ITGA1, ACTG2, ACTC1, ACTN1, RAP2A, RAPGEF1
PI 0.275 0.039 PIK3C2B, PAK4, MYL2, TSPAN7, PIK3R4, ACTC1, TTN, ITGB3
TGF-β Signaling GL 0.008 0.145 SMAD2, BMPR1B, JUN, SMAD9, TGFB1, MRAS, TGFB3, TGFB2, SMAD6, PITX2, SMAD1, INHBB
PI 0.228 0.048 SMAD2, TGFB1, TGFB3, INHBB
Wnt/β-catenin Signaling GL 0.019 0.114 AKT2, SFRP2, APPL2, PPARD, WNT2B, MARK2, GNAQ, APPL1, CDH2, JUN, TGFB1, CSNK2A1, TGFB2, TGFB3, NR5A2, FZD5, LEF1,
SFRP1, PPP2R5E, TCF7L2
PI 0.046 0.057 CDH2, CDH1, PPP2R4, TGFB1, PPP2R2B, CD44, TGFB3, FZD6, TLE1, PPP2R5A
Cyclins and Cell Cycle
Regulation
GL 0.023 0.124 CCND3, PA2G4, HDAC8, TGFB1, E2F1, HDAC7, E2F5, TGFB3, TGFB2, PPP2R5E, SKP2
PI 0.003 0.090 CCNE2, PPP2R4, TGFB1, PPP2R2B, TGFB3, CCNB2, ATR, PPP2R5A
Aryl Hydrocarbon Receptor
Signaling
GL 0.007 0.116 ALDH4A1, NFIC, MED1, HSPB2, CYP1B1, CTSD, ALDH1A1, JUN, CCND3, NCOA2, TGFB1, E2F1, TGFB3, TGFB2, IL1B, NFIB, NCOR2,
ESR1
PI 0.004 0.071 ALDH4A1, CCNE2, ALDH1A1, TGFB1, TGFB3, IL1B, ALDH18A1, NCOR2, ATR, ESR1, NCOA3
Gα12/13 Signaling GL 0.043 0.109 F2RL2, AKT2, F2R, MYL2, MAPK12, LPAR3, CDH11, MYL9, CDH2, IKBKG, JUN, LPAR1, MRAS, MAPK7
PI 0.005 0.078 PIK3C2B, CDH2, CDH1, IKBKG, MYL2, MEF2C, MAP3K5, MAPK7, PIK3R4, MYL6B
Glucocorticoid Receptor
Signaling
GL 0.025 0.095 ICAM1, GTF2A2, TSC22D3, IKBKG, JUN, NCOA2, TGFB1, MRAS, TGFB2, GTF2H5, POLR2H, NCOR1, FKBP5, TAF12, SMAD2, STAT5A,
AKT2, MED1, TAF15, CEBPB, MAPK12, NCOA1, TGFB3, IL1B, PTGS2, NCOR2,ESR1
PI 0.033 0.049 SMAD2, PIK3C2B, SMARCD2, CEBPB, PIK3R4, NCOA3, TSC22D3, IKBKG, TGFB1, TGFB3, IL1B, NCOR2, PTGS2, ESR1
Ceramide Signaling GL 0.352 0.078 CTSD, AKT2, JUN, TNFRSF1A, MRAS, PPP2R5E, TNFRSF1B
PI 0.044 0.067 PIK3C2B, PPP2R4, TNFRSF1A, PPP2R2B, PIK3R4, PPP2R5A
PPARα/RXRα Activation GL 0.002 0.123 PPARA, SMAD2, MED1, ADCY3, GNAQ, ADCY6, MAP4K4, CAND1, PLCD1, PLCD3, IKBKG, PLCB4, JUN, TGFB1, FASN, IRS1, MRAS,
TGFB3, TGFB2, IL1B, NCOR1, NCOR2, INSR
PI 0.020 0.059 PLCD1, SMAD2, IKBKG, TGFB1, GNA11, ADCY6, TGFB3, IL1B, NCOR2, NCOA3, ABCA1
RhoA Signaling GL 0.019 0.127 MYL2, RDX, WASF1, DLC1, LPAR3, MYLK, MYL9, LPAR1, IGF1R, PPP1R12A, CDC42EP1, ACTG2, ACTC1, PI4KA
PI 0.007 0.082 RHPN2, IGF1, MYL2, EPHA1, IGF1R, ARHGAP12, MYL6B, ACTC1, TTN
Tight Junction Signaling GL 0.004 0.127 MYH10, F2RL2, TIAM1, AKT2, MYL2, TNFRSF1A, PVRL3, MARK2, MYH11, CASK, MYL9, MYLK, JUN, TGFB1, TGFB3, TGFB2, MYH9,
ACTG2, PPP2R5E, TNFRSF1B, ACTC1






















Table 1 Assignment of temporally regulated DE-genes to canonical pathways in German Landrace and Pietrain, respectively (Continued)
Estrogen-Dependent Breast
Cancer Signaling
GL 0.076 0.110 STAT5A, AKT2, JUN, CREB3, IGF1R, MRAS, HSD17B7, ESR1
PI 0.014 0.082 PIK3C2B, IGF1, IGF1R, PIK3R4, ESR1, HSD17B8
Mitotic Roles of Polo-Like Kinase GL 0.424 0.079 CDC25B, TGFB1, CDC23, PPP2R5E, ANAPC13
PI 0.012 0.095 PPP2R4, TGFB1, PPP2R2B, CCNB2, CDC27, PPP2R5A
PPAR Signaling GL 0.000 0.170 PPARA, STAT5A, TNFRSF1A, PPARD, MED1, MAP4K4, IKBKG, JUN, NCOA1, MRAS, IL1B, NCOR1, PTGS2, NCOR2, INSR, TNFRSF1B,
CITED2, PDGFRB
PI 0.081 0.057 IKBKG, TNFRSF1A, IL1B, NCOR2, PTGS2, PDGFRB
Role of Tissue Factor in Cancer GL 0.164 0.095 FYN, STAT5A, YES1, AKT2, PTPN11, MRAS, GNAQ, IL1B, GNA14, RPS6KA1, MAPK12
PI 0.009 0.078 PIK3C2B, CTGF, CSF1, GNA11, VEGFC, IL1B, RPS6KA1, PIK3R4, ITGB3
TR/RXR Activation GL 0.010 0.130 AKT2, NXPH2, MED1, THRA, KLF9, SCARB1, COL6A3, NCOA2, FASN, NCOA1, STRBP, NCOR1, NCOR2
PI 0.063 0.060 KLF9, PIK3C2B, COL6A3, NCOR2, PIK3R4, NCOA3
1pathways are shown that were significant at p< 0.05 according to Fishers exact test in at minimum one of the three types of comparisons.






















Table 2 Assignment of DE-genes to canonical pathways in the comparison between breeds at either 63 dpc or 91 dpc
Ingenuity Canonical
Pathways
PI vs. GL at 63




63 0.011 0.222 EPS15, STON2, CDC42, FGF2, ARPC5, NUMB, SH3GL2, ITGB8, PIK3R4, CD2AP, ACTR3, WASL, SNX9, IGF1, PIK3C3, ARPC3, DAB2,
STAM, AAK1, PPP3CA, ACTA1, ATM, ITGB1, MYO6, ACTR2, PIK3C2A, SH3GL3, ACTB, CLTC, RAB7A, MET, CBL, SYNJ1, ARPC2,
RAB11A, TFRC, UBC, PDGFD
91 0.106 0.029 EPS15, FGF2, TFRC, DAB2, AAK1
Corticotropin Releasing
Hormone Signaling
63 0.033 0.204 RAP1B, PRKACB, RAF1, MAPK1, ARPC5, CREB5, PRKAG1, PRKD3, PRKCA, null, ITPR2, CNR1, PTCH1, GNAQ, GNAI1, ADCY6,
MAPK12, RAP1A, ATF2, GNAS, GNAI3, PRKCI, MAPK14, PRKAR2B, PRKAG2, PRKCH, GLI1, PRKCB
91 0.258 0.022 PRKAR2B, ADCY3, PTGS2
Integrin Signaling 63 0.000 0.259 MAP2K4, RAP2B, RAF1, MYL2, MAPK1, ARPC5, ITGA8, KRAS, PIK3R4, PTEN, TSPAN3, RHOG, ARF4, CAV1, ITGAV, GSK3B, ACTA1,
ATM, CAPN5, ACTR2, BCAR3, RAP1A, TTN, RHOQ, RND3, ARPC2, PPP1R12A, CAPN7, TSPAN6, RAP1B, FYN, PPP1CC, RALA,
CDC42, PPP1CB, ITGB8, SHC1, ACTR3, WASL, RHOT1, PIK3C3, SOS1, ARPC3, ITGB1, PAK2, PIK3C2A, ASAP1, ACTB, ITGA2,
MAPK8, ROCK1, WIPF1, ITGAX
91 0.191 0.024 RALA, ASAP1, ARF4, ITGA8, TTN
PI3K/AKT Signaling 63 0.048 0.197 RAF1, MAPK1, INPPL1, KRAS, JAK2, MAP3K5, EIF4E, PTEN, BCL2, SHC1, IKBKG, SOS1, TSC2, GSK3B, MCL1, ITGB1, RPS6KB1,
YWHAG, PPP2R5C, ITGA2, TYK2, YWHAZ, PPP2R5A, PPP2CB, GAB1, CDKN1B, PPP2R5E, PPP2R1B
91 0.296 0.021 PTGS2, PPP2R5A, BCL2
α-Adrenergic Signaling 63 0.012 0.236 PRKACB, RAF1, MAPK1, GNB5, KRAS, PRKAG1, PHKA2, GNB1, GNB4, PHKB, PRKD3, PRKCA, null, ITPR2, GNAI1, ADCY6, GNAQ,
GNAS, GNAI3, PRKCI, PRKAR2B, PRKAG2, PRKCH, GNG2, PRKCB
91 0.404 0.019 PRKAR2B, ADCY3
IL-15 Signaling 63 0.047 0.229 STAT5A, RAF1, PIK3C2A, MAPK1, TYK2, KRAS, JAK2, AXL, MAPK12, PIK3R4, BCL2, SHC1, MAPK14, PIK3C3, SYK, ATM
91 0.267 0.029 STAT6, BCL2
Myc Mediated Apoptosis
Signaling
63 0.018 0.266 MAP2K4, YWHAG, PIK3C2A, MAPK8, YWHAZ, MAPK9, KRAS, PIK3R4, MAPK12, BCL2, SHC1, IGF1, PIK3C3, SOS1, CYCS, BID,
ATM
91 0.255 0.031 APAF1, BCL2
Protein Kinase A Signaling 63 0.000 0.228 PRKACB, MYH10, RAF1, TGFBR1, MAPK1, MYL2, PDE12, GNB5, AKAP3, CREB5, PPP1R14B, TGFBR2, GNB1, GNB4, PHKB, CAMK2A,
TDP2, GSK3B, PRKD3, null, YWHAG, ITPR2, PTCH1, CREBBP, YWHAZ, RAP1A, MYL6B, TTN, ATF2, MYL9, AKAP13, ANAPC4,
ANAPC5, PPP1R12A, PRKCH, LEF1, GNG2, PDE6D, AKAP12, RAP1B, PPP1CC, FLNB, PDE7A, AKAP8, PDIA3, PPP1CB, H3F3A/
H3F3B, CDC23, PRKAG1, PHKA2, NFAT5, TGFB2, SMAD4, PPP3CA, PRKCA, AKAP5, ATF1, MAP3K1, ADCY6, GNAI1, GNAQ,
ANAPC13, ROCK1, GNAS, GNAI3, PPP1R3D, PRKAR2B, PRKCI, ADD3, KDELR2, PRKAG2, AKAP9, PRKCB, ANAPC1
91 0.348 0.019 ADD3, PRKAR2B, ADCY3, AKAP3, AKAP7, TTN
Molecular Mechanisms of
Cancer






91 0.017 0.029 PRKAR2B,RALA,FZD4,ADCY3,APAF1,RAPGEF3,E2F3,CASP7,E2F2,WNT5A,BCL2
p53 Signaling 63 0.000 0.293 GADD45G, PIK3R4, PTEN, CHEK1, BCL2, RB1, CASP6, GADD45A, PIK3C3, GSK3B, HIPK2, ATM, TP53INP1, TP63, PIK3C2A, TOPBP1,
MED1, THBS1, HDAC1, PERP, MAPK8, TP53BP2, KAT2B, PCNA, MAPK14, E2F1, ATR, CDK2, SIRT1






















Table 2 Assignment of DE-genes to canonical pathways in the comparison between breeds at either 63 dpc or 91 dpc (Continued)
VDR/RXR Activation 63 0.003 0.284 CYP24A1, SPP1, CCNC, MED1, IGFBP5, CEBPB, THBD, KLF4, NCOA3, GTF2B, PRKCI, SP1, GADD45A, NCOA2, MXD1, NCOA1,
IGFBP3, TGFB2, PRKCH, CDKN1B, PRKD3, PRKCA, PRKCB
91 0.124 0.037 CYP24A1, MED1, MXD1
Breast Cancer Regulation by
Stathmin1
63 0.000 0.248 PRKACB, RAF1, CAMK1D, MAPK1, GNB5, KRAS, ARHGEF1, PIK3R4, PPP1R14B, GNB1, GNB4, CAMK2A, PRKD3, ATM, null, ITPR2,
PPP2CB, E2F1, PPP1R12A, PRKCH, GNG2, CDK2, PPP1CC, CDC42, PPP1CB, E2F3, PRKAG1, SHC1, PIK3C3, SOS1, RB1CC1, E2F5,
PRKCA, ARHGEF12, PIK3C2A, PPP2R5C, GNAI1, TUBA4A, ADCY6, GNAQ, PPP2R5A, ROCK1, GNAS, GNAI3, PPP1R3D, PRKCI,
PRKAR2B, PRKAG2, CDKN1B, PPP2R5E, PPP2R1B, PRKCB
91 0.191 0.024 PRKAR2B, ADCY3, E2F3, E2F2, PPP2R5A
ERK/MAPK Signaling 63 0.001 0.230 RAP1B, PRKACB, FYN, PPP1CC, RAF1, MAPK1, HSPB2, H3F3A/H3F3B, ETS2, PPP1CB, KRAS, CRK, PIK3R4, CREB5, PPP1R14B, EIF4E,
PRKAG1, SHC1, PIK3C3, SOS1, MKNK1, PRKCA, ATM, ITGB1, MYCN, PAK2, YWHAG, PPP2R5C, ATF1, PIK3C2A, ITGA2, YWHAZ,
MAPKAPK5, RAP1A, PPP2R5A, ATF2, PLA2G4A, PPP2CB, PPP1R3D, PRKCI, PRKAR2B, PRKAG2, PPP1R12A, PPP2R5E, PPP2R1B,
ELK3, PRKCB
91 0.556 0.015 PRKAR2B, RAPGEF3, PPP2R5A
RAR Activation 63 0.001 0.246 MAP2K4, PRKACB, NSD1, MAPK1, MAP3K5, JAK2,RBP1, PRKAG1, PTEN, PNRC1, TGFB2, SMAD4, GTF2H5, NR2F6, RDH13, PRKD3,
CITED2, PRKCA, STAT5A, SMAD2, SRA1, PRMT2, IL3RA, RDH14, MED1, RDH11, MAP3K1, CREBBP, MAPK8, ADCY6, MAPK9,
MAPK12, CRABP1, PARP1, KAT2B, PRKCI, MAPK14, PRKAR2B, TAF4, ERCC3, IGFBP3, NCOA1, PRKAG2, PRKCH, PRKCB
91 0.269 0.022 PRKAR2B, MED1, ADCY3, RDH13
1pathways are shown that were significant at p< 0.05 according to Fishers exact test in at minimum one of the three types of comparisons.






















Figure 6 Comparison of microarray (left y-axis) and quantitative real time PCR (right y-axis) data of five genes. Graphs show log(2) mean
values of transcript abundance of the breed categories `German Landrace´ (GL), and `Pietrain´ (PI) at the prenatal stage of 63 and 91 day post
conception `GL63´, `GL91´, `PI63´ and `PI91´.
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http://www.biomedcentral.com/1471-213X/12/13hematopoietic cells during embryogenesis and branching
morphogenesis of epithelial cells. The deficiency of GAB1
results in the lack of ligands, receptors and signaling
molecules and develop the organs [30-34].Mitogen-activated protein kinase 9 (MAPK9), which is
known as c-Jun NH2-terminal kinase 2 (JNK2), is a
member of the MAP kinase family. It also enhances in the
signal transduction pathways. MAPKs are regulated
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http://www.biomedcentral.com/1471-213X/12/13through cascades composed of MAPK, MAPK kinase
(MAPKK, MKK or MEK) and MAPKK kinase or MEK
kinase (MAPKKK or MEKK). These kinases are activated
through hormones and growth factors that act via
RTKs (e.g. EGF, PDGF and FGF) or cytokine receptors
(e.g. growth hormone). MAPKs function in gene transcrip-
tion, protein synthesis, cell cycle, cell death, and cell differ-
entiation. MAPKs may involve in epithelial-mesenchymal
transition (EMT). The overexpression of MAPK induced
cell migration and invasion, a morphologic change in
EMT. The lack of MAPK increasing tumor aneuploidy
and reduced DNA damage [35-40].
Phosphoinositide-3-kinase, class 3 (PIK3C3) and phos-
phoinositide-3-kinase, class 2, beta polypeptide (PIK3C2B)
belong to the phophoinositide-3-kinase (PI3K) family.
PI3Ks are a family of unique and conserve intracellular
lipid kinases that are activated by growth hormones, RTKs
and G-protein-coupled receptors (GPCRs). PI3Ks are
capable of phosphorylation the 3´-hydroxyl group of phos-
phatidylinositol 4,5 diphosphate (PIP2) to generate phos-
phatidylinositol-3,4,5-trisphosphate (PIP3), which activates
intracellular signaling pathways for regulated function in
cell growth and proliferation, cell migration, and cell
metabolism. PI3Ks can induce the differentiation of cells
of epithelial or mesenchymal origin. During EMT, TGFß
signaling co-operates with Rho signaling to activate PI3K.
PRL-3 signals through PI3K and then leads to EMT [41-45].
PIK3C3 homozygous mutant causes cell proliferation
defect, embryonic lethal and death [46].
Protein kinase C, eta (PRKCH) is calcium independent
and phospholipids dependent member of the protein
kinase C (PKC) family. PKC, a family of serine and
threonine - specific protein kinases, has important roles
in cell proliferation, survival, migration and adhesion.
PKC is activated via lipid activators and phosphorylation.
PKC are classified into α, ßI, ßII, γ, δ, , η (L), θ, μ, ξ, λ
isoforms. PKC is predominantly a cytosolic enzyme in
the mammary gland and have a role in prolactin (PRL)
to stimulate lactogenic processes. PKC- α isoform has a
role in mammary cell differentiation, while PKC- δ
isoform is mediated by MEK/ERK pathway and induce
the production of proteolytic enzymes [47-52].
Conclusions
The study provides a holistic view on the gene expression
during prenatal development addressing the abundance of
11,731 probe sets at two fetal stages at the phase of
growth and protrusion of mammary buds in two pig
breeds. It is shown that the development in PI precedes
GL in a way that processes of differentiation, maintenance,
and maturation are predominant whereas in GL still
proliferative processes are prevalent. These differences in
fetal development have implications on the postnatal
phenotypes. Due to divergent selection pressure, GL andPI differ in the number of teats and in functional morpho-
logical criteria of mammary complex quality, like position
and symmetry, shape, and functionality. In particular there
is large divergence in the prevalence of inverted teats, a
disorder characterized by the formation of non-functional
teats. We hypothesed that differential expression between
the two breeds at fetal stages reflect the prenatal initiation
of postnatal phenotypes also in terms of the liability to
emerge inverted teats. We have previously identified mo-
lecular routes that are differentially regulated in normal
compared to inverted teats at peripubertal stages [11,13].
We questioned here, whether these molecular routes are
already relevant at prenatal stages and thus their modula-
tion may initiate the postnatal development. In fact, the
DE-genes were mainly from signaling pathways that are
known to have implication for mammary gland develop-
ment. The finding of overwhelming importance of signal-
ing pathways in teat development and of differential
expression of related genes, which suggest a prolonged
proliferative development in the breed GL selected against
undesired teat phenotypes and which potentially promotes
the emergence of inverted teats, is in line with our previ-
ous findings when comparing normal and inverted teats at
postnatal stages [13].Materials and methods
Sample collection and RNA preparation
Animal care and tissue collection processes followed the
guidelines of the German Law of Animal Protection, and
the experimental protocol was approved by the Animal
Care Committee of the Leibniz Institute for Farm Animal
Biology (FBN, Dummerstorf, Germany). The milk lines
samples were collected from14 fetuses of sows of the breed
German Landrace (GL) and the Pietrain (PI) at the 63 and
91 days post conception (dpc) (63 dpc GL n=4; 91 dpc
GL n=4; 63 dpc PI n =3; 91 dpc PI n= 3, respectively).
After collected, the samples were immediately frozen in
liquid nitrogen and stored at −80°C.
For isolation of total RNA, nipples were prepared from
the milk line tissues with scalpel and grinded in a mor-
tar under liquid nitrogen. Then they were homogenized
with 1 ml Trizol Reagent (Sigma-Aldrich, Taufkirchen,
Germany) by using syringes and needles and cleaned up
with the NucleoSpin RNA II kit (Macherey-Nagel,
Düren, Germany). In addition, the DNAse treatment
was done according to the manufacturer’s protocol.
After that, the integrity of the RNA samples were
checked by visualizing them on 1.5% agarose gel con-
tained formaldehyde stained with ethidium bromide.
The concentration levels of RNA were measured by a
Nano Drop ND-1000 Spectrophotometer (PEQLAB,
Erlangen, Germany). The absence of DNA contamin-
ation was checked by using the RNA as a template in
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phosphate dehydrogenase (GAPDH) gene. All RNAs
were stored at −80°C for further analysis.
Microarray analysis
Affymetrix GeneChip Porcine Genome Arrays (Affymetrix,
St. Clara, USA) containing 24,123 probe sets were used
in the expression study. A total 14 RNA samples from
different breeds and stages were used for the array
hybridization. cDNA was synthesized from total RNA and
used to generate biotin-labeled cRNAs target according to
the Affymetrix protocol. The biotinylated cRNA was
fragmented and used for hybridization to the Affymetrix
Gene Chips at 45°C for 16 hours. Hybridization, washing,
and scanning of the arrays were done according to the
manufacturer’s recommendation. The data were analyzed
with the Affymetrix GCOS 1.1.1 software by using the
global scaling to a target signal of 500.
Statistical analysis
The raw intensity files (*.cel) were used in microarray
data analysis with the Affymetrix Expression Console
software (Affymetrix, St. Clara, USA). First the data were
processed with the MAS5.0 algorithm to generate probe
cell intensity values, i.e. single expression value for each
probe set that are derived from intensities of pairs of
perfect-match probes and mismatch probes, and to evalu-
ate presence and absence of transcripts. Using default
settings (detection p-values of <0.04 for `present´, ≥0.04
and ≤0.06 for `marginal´, and <0.06 for `absent´) only
`present´ calls were used. The subsequent data processing,
including background correction, probe summarization
and normalization, was performed using the probe loga-
rithmic intensity error (PLIER) algorithm that reveal sum-
mary values for the probe sets (Affymetrix 2001, 2005).
The microarray data related to all samples were deposited
in the Gene Expression Omnibus public repository (GEO
accession number: GSE32956). The probe intensity value
obtained by the PLIER algorithm were transformed to
logarithms and evaluated by analysis of variance taking
into account the effects of stage and breed and their inter-
action to detect genes differentially regulated at p< 0.05
(JMP Genomics). Corresponding q-values were calculated
according to algorithms established by Storey [53] using
QVALUE. Based on BLAST comparison of the Affymetrix
porcine target sequences with the porcine genome sequence
(Ensembl_Sscrofa_9), 20,689 of the 24,123 probe sets on the
Affymetrix Porcine GeneChip were annotated [54]. This
source of annotation was used in this study for Ingenuity
Pathways Analysis (IPA) (Ingenuity Systems, http://www.
ingenuity.com). The Ingenuity applications were used to
generate networks and assess statistically relevant biofunc-
tions and canonical pathways associated with the micro-
array data. The significance of the association between thedataset of differentially expressed genes (DE-genes) and
the predefined pathways and functional categories of the
Ingenuity Knowledge Base was measured by Fischer’s
exact test and adjusted using the Benjamini–Hochberg
correction, providing a p-value, which would determine the
probability that the association between the genes in the
dataset and the pathway is explained by chance alone.
Quantitative real time PCR
1 μg of total RNA of the same individual samples used
for microarray analysis were reverse transcribed with
Super Script III with Oligo (dT) and random primers
(Invitrogen, Karlsruhe, Germany) in a total volume of
10 μl. The cDNAs were used as the template for
validation of the gene expression levels by quantitative RT-
PCR in duplicate. Quantitative RT-PCR was conducted
with the LightCycler 480 system (Roche, Mannheim,
Germany). The reaction volume of 10 μl contained 5.0 μl
of LightCycler 480 SYBR Green I Master (Roche), 600 nM
of each primer, and 2 μl of cDNA. Amplification condi-
tions were 95°C for 10 min, 40 cycles of 95°C for 15 sec,
60°C (annealing) for 10 sec and 72°C for 15 sec. The pri-
mers were designed from Affymetrix core sequence with
Primer3 (http://frodo.wi.mit.edu/primer3). The list of pri-
mer sequences is provided in Table S1 (Additional file 2).
Standard curves were derived for each gene from a serial
dilution of cDNAs. For all the assays threshold cycles were
converted to copy numbers using the standard curves gen-
erated by amplifying serial dilutions of an external PCR
standard (107 - 102 copies). At the completion of the amp-
lification protocol, all samples were subjected to melting
curve analyses and gel electrophoresis to verify the ab-
sence of any non-specific product. Copy numbers of the
house keeping genes HPRT1 and RPL32 were obtained
from each individual sample to enable accounting for
variation in RNA input and efficiency of reverse transcrip-
tion by normalization when calculating mRNA copy num-
bers of the target genes. Both of the reference genes were
checked for lack of variation on the basis of microarray
data at prenatal and postnatal stages [13,55]. Data were
analyzed like microarray data by analysis of variance in-
cluding the effects of stage and breed (JMP Genomics).
Differences were considered significant at p< 0.05.
Additional files
Additional file 1: Figure S1. Significant biofunctions (top 20 according
to p-value) representing genes differentially expressed between 63 dpc
and 91 dpc in Pietrain and German Landrace. All assignments significant
after Benjamini–Hochberg correction.
Additional file 2: Table S1. List of genes and corresponding primers
used for quantitative RT-PCR. 1Reference genes.
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